- Report
- April 2025
- 384 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 372 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 66 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 235 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 74 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 66 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 72 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- April 2025
- 372 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- September 2024
- 257 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more